CERTEST
Founded in Zaragoza, Spain, in 2002, Certest Biotec is a leading biotechnology company specializing in in vitro diagnostics (IVD) for detecting viruses, bacteria, and parasites. Over two decades, Certest has expanded its reach to over 130 countries, delivering innovative diagnostic solutions to healthcare providers worldwide. With a team of more than 300 highly skilled professionals, the company combines scientific expertise and technological innovation to address global healthcare challenges, firmly establishing itself as a trusted leader in clinical diagnostics.
Certest’s advanced facilities include state-of-the-art molecular biology laboratories, clean rooms, and scalable production areas, spanning over 7,000 m². These facilities are not only designed to meet stringent quality requirements, certified under ISO 13485, but also reflect the company’s commitment to sustainability through the integration of energy-efficient technologies like photovoltaic solar systems. The infrastructure supports their capacity for high-volume production and rapid response to emerging diagnostic needs, ensuring reliable solutions on a global scale.
Guided by a mission to provide reliable, cutting-edge diagnostic tools, Certest continues to prioritize research and development as a cornerstone of its growth. By identifying new market opportunities and developing innovative products, the company seeks to advance diagnostic capabilities and improve patient outcomes. Their dedication to quality, innovation, and customer satisfaction drives their vision to lead the global IVD industry and make a lasting impact on global healthcare.
ARAID
Founded in 2005 by the Government of Aragon, ARAID (Aragonese Agency for Research and Development) is a non-profit foundation with a clear mandate: to promote research, development and innovation as key drivers of regional progress. Operating across six major scientific domains — Biomedical Sciences, Social Sciences, Experimental and Mathematical Sciences, Human Sciences, Agricultural and Veterinary Science, and Technological Sciences — ARAID acts as a strategic bridge between academic excellence and the broader needs of Aragonese society.
ARAID’s primary activity is the recruitment and stabilization of outstanding researchers, through competitive international calls open to talented scientists with internationally recognized track records. Since its inception, the Foundation has attracted more than 118 researchers to Aragon, whose combined scientific output exceeds one thousand published articles, hundreds of conference presentations, and dozens of patents. These researchers have participated in over 715 projects, generating more than 200 million euros in funding, of which approximately 52 million have been directly invested in the region.
Committed to making Aragon an attractive and stable destination for scientific careers, ARAID also promotes interdisciplinary debate, supports institutions in securing competitive funding, and fosters collaboration between academia, industry, and public administration. Its support for MycoJaca26 reflects this mission — backing frontier research in mycobacterial systems biology and contributing to the fight against tuberculosis as a global health priority.
